Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Sapheon Submits First Module of PMA Application for VenaSeal® Sapheon Closure System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/20/2013 | 12:05am EDT

Sapheon Inc. announced today that it submitted the first module of the pre-market approval (PMA) application for the VenaSeal® Sapheon Closure System to the U.S. Food and Drug Administration (FDA). The submission places Sapheon on track for timely FDA review and expected product launch in the first half of 2015. VenaSeal is a minimally invasive, single use kit intended for the treatment of venous reflux (varicose veins) disease. The device is currently under clinical investigation in a 1:1 randomized pivotal study (the VeClose Study) to determine its safety and effectiveness compared to radio frequency thermal ablation.

"VenaSeal represents a novel approach to the treatment of venous reflux disease," said Monte Madsen, Vice President, Clinical Affairs for Sapheon. "It is designed to eliminate the need for tumescent anesthesia by using our proprietary medical adhesive to close the great saphenous vein instead of heat to burn and destroy the vein."

The VeClose Study is authorized under an investigational device exemption (IDE) approved by the FDA in December 2012. Clinical investigators at 10 sites in the U.S. have treated 242 patients in the study. In addition to the VeClose Study, Sapheon is sponsoring two other VenaSeal studies: a 70-patient European post-market evaluation at seven sites within Germany, the UK, The Netherlands and Denmark that completed enrollment in September 2012; and a 38-patient feasibility study conducted in the Dominican Republic that completed enrollment in July 2011. The clinical data collected in these studies will be used to support the PMA application as well as to support product reimbursement activities in markets outside the United States.

The VenaSeal Sapheon Closure System received CE Mark approval in September 2011. Since that time, VenaSeal has been used to treat over 1,000 veins in patients in Europe and Hong Kong without tumescent anesthesia or the need for post-procedure compression hose therapy.

ABOUT SAPHEON

Sapheon Inc. is a privately held medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease. The Company's current focus is on an advanced treatment for venous reflux disease, a condition requiring over 550,000 surgical procedures worldwide in 2012. VenaSeal® uses a proprietary medical adhesive to close the saphenous vein, eliminating the need for surgery, ablation, sedatives, anesthesia, and the use of harsh chemicals. The VenaSeal Sapheon Closure System is not commercially available in the United States. Please visit www.sapheoninc.com to learn more about Sapheon.

Sapheon Inc.
Harry Phillips, 919-948-3987
harry.phillips@sapheon.net


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
07:45aTRANSFER PREDICTOR : Moussa Dembele to Man United gets 8, Spurs double swoop a 4
AQ
07:44aSOUTHWEST AIRLINES : Regulators fail to set date for 737 MAX return
AQ
07:36aP I A C A : PIA and Askari Bank to launch Co-Branded Credit Card - Press Release issued by Pakistan International Airlines
AQ
07:36aORACLE COALFIELDS : Power's Chinese partners revise stake in Thar project
AQ
07:36aINDUS MOTOR : awarded
AQ
07:36aK ELECTRIC : signs deal with CMEC for 700MW plant at Port Qasim
AQ
07:36aNESTLE PAKISTAN : earns Rs2.2bln in Jan-March
AQ
07:31aGEICO : 's Tips for Sharing the Road with Motorcycles
BU
07:17aFG probes $2bn Atlas Mara alleged share fraud in Union Bank
AQ
07:15aRIZAL COMMERCIAL BANKING : RCBC brass innocent of laundering charges, bank says
AQ
Latest news "Companies"
Advertisement